Inspired by the oral presentations and panel discussions at the recent HTAi Conference in Utrecht, The Netherlands, Persefoni Ioannou (Consultant – Health Technology Assessment [HTA]) shares some key trends in...
Read More
Kimrin Pannu recently joined Mtech Access as an Analyst working in market access. In this interview, she tells us about what inspired her to pursue a career in market access,...
Read More
Ginny Deimantaviciute and Kirsty Alsop recently joined Mtech Access as Associate Medical Writers. In this interview, they tell us about what led them to a career in medical writing, to...
Read More
Emma Frood recently joined Mtech Access as an Associate Consultant in our market access team. In this interview, she tells us about her experiences and activities in her first few...
Read More
Patient-centric design, ingenuity and a resilient drive to get new technologies to market were all on display at Medtech Innovation Expo. On 8th–9th June 2022 Calum Jones, Lily Westbrook and...
Read More
We sit down with Emily Mair to learn more about her work as an Associate Consultant and how her career has developed, following earlier commercial roles. She shares her highlights...
Read More
In this webinar, we explored the challenges facing orphan medicines and other innovative rare disease treatments looking to achieve market access in Europe. Orphan medicines and rare disease treatments are...
Read More
Katriona Withers recently joined Mtech Access as a Senior Analyst working on global market access projects. In this interview, she tells us about her experiences and activities in her first...
Read More
Charlotte Harding and Katie Mulholland recently joined Mtech Access as Associate Consultants, working with teams across Mtech Access to support a range of multi-disciplinary projects. In this interview Charlotte and...
Read More
Guest author Professor Fabrizio Gianfrate shares his thoughts on how spending priorities have shifted in the pandemic, how they may further evolve in a post-COVID era, and how European agencies...
Read More
